173 related articles for article (PubMed ID: 26540494)
1. Anti-HIV-1 activity of a tripodal receptor that recognizes mannose oligomers.
Rivero-Buceta E; Carrero P; Casanova E; Doyagüez EG; Madrona A; Quesada E; Peréz-Pérez MJ; Mateos R; Bravo L; Mathys L; Noppen S; Kiselev E; Marchand C; Pommier Y; Liekens S; Balzarini J; Camarasa MJ; San-Félix A
Eur J Med Chem; 2015 Dec; 106():132-43. PubMed ID: 26540494
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors.
Patel M; Cianci C; Allard CW; Parker DD; Simmermacher J; Jenkins S; Mcauliffe B; Minassian B; Discotto L; Krystal M; Meanwell NA; Naidu BN
Bioorg Med Chem Lett; 2020 Nov; 30(21):127516. PubMed ID: 32860982
[TBL] [Abstract][Full Text] [Related]
3. Advances in the development of HIV integrase strand transfer inhibitors.
Wang Y; Gu SX; He Q; Fan R
Eur J Med Chem; 2021 Dec; 225():113787. PubMed ID: 34425310
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of HQCAs with aryl or benzyl substituents on N-1 position as potential HIV-1 integrase inhibitors.
He QQ; Zhang X; Wu HQ; Gu SX; Ma XD; Yang LM; Zheng YT; Chen FE
Bioorg Med Chem; 2011 Sep; 19(18):5553-8. PubMed ID: 21862337
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD
Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of (E)-3,4-dihydroxystyryl 4-acylaminophenethyl sulfone, sulfoxide derivatives as dual inhibitors of HIV-1 CCR5 and integrase.
Sun Y; Xu W; Fan N; Sun X; Ning X; Ma L; Liu J; Wang X
Bioorg Med Chem; 2017 Feb; 25(3):1076-1084. PubMed ID: 28082070
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N
Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851
[TBL] [Abstract][Full Text] [Related]
8. Novel Benzoxazin-3-one Derivatives: Design, Synthesis, Molecular Modeling, Anti-HIV-1 and Integrase Inhibitory Assay.
Safakish M; Hajimahdi Z; Vahabpour R; Zabihollahi R; Zarghi A
Med Chem; 2020; 16(7):938-946. PubMed ID: 31448713
[TBL] [Abstract][Full Text] [Related]
9. Diketoacid chelating ligands as dual inhibitors of HIV-1 integration process.
Rogolino D; Carcelli M; Compari C; De Luca L; Ferro S; Fisicaro E; Rispoli G; Neamati N; Debyser Z; Christ F; Chimirri A
Eur J Med Chem; 2014 May; 78():425-30. PubMed ID: 24704615
[TBL] [Abstract][Full Text] [Related]
10. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 5-fluoroquinolone-3-carboxylic acids as potential HIV-1 integrase inhibitors.
He QQ; Zhang X; Yang LM; Zheng YT; Chen F
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):671-6. PubMed ID: 22468749
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Molecular Modelling and Biological Studies of 3-hydroxypyrane- 4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors.
Sirous H; Fassihi A; Brogi S; Campiani G; Christ F; Debyser Z; Gemma S; Butini S; Chemi G; Grillo A; Zabihollahi R; Aghasadeghi MR; Saghaie L; Memarian HR
Med Chem; 2019; 15(7):755-770. PubMed ID: 30569867
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integrase.
Sari O; Roy V; Métifiot M; Marchand C; Pommier Y; Bourg S; Bonnet P; Schinazi RF; Agrofoglio LA
Eur J Med Chem; 2015 Nov; 104():127-38. PubMed ID: 26451771
[TBL] [Abstract][Full Text] [Related]
15. The complestatins as HIV-1 integrase inhibitors. Efficient isolation, structure elucidation, and inhibitory activities of isocomplestatin, chloropeptin I, new complestatins, A and B, and acid-hydrolysis products of chloropeptin I.
Singh SB; Jayasuriya H; Salituro GM; Zink DL; Shafiee A; Heimbuch B; Silverman KC; Lingham RB; Genilloud O; Teran A; Vilella D; Felock P; Hazuda D
J Nat Prod; 2001 Jul; 64(7):874-82. PubMed ID: 11473415
[TBL] [Abstract][Full Text] [Related]
16. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
17. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of imidazole and oxazole fragments as HIV-1 integrase-LEDGF/p75 disruptors and inhibitors of microbial pathogens.
Rashamuse TJ; Harrison AT; Mosebi S; van Vuuren S; Coyanis EM; Bode ML
Bioorg Med Chem; 2020 Jan; 28(1):115210. PubMed ID: 31753802
[TBL] [Abstract][Full Text] [Related]
19. Authentic HIV-1 integrase inhibitors.
Liao C; Marchand C; Burke TR; Pommier Y; Nicklaus MC
Future Med Chem; 2010 Jul; 2(7):1107-22. PubMed ID: 21426159
[TBL] [Abstract][Full Text] [Related]
20. Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products.
Singh SB; Ondeyka JG; Schleif WA; Felock P; Hazuda DJ
J Nat Prod; 2003 Oct; 66(10):1338-44. PubMed ID: 14575434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
